Vontobel Swiss Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Vontobel Swiss Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$276K	Buy	+27,895	New	+$295K	0.14%	73

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Vontobel Swiss Wealth Advisors's TEVA Position: Q2 2021 in Review

Vontobel Swiss Wealth Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2021: 27,895 shares worth $276K. The stake represents 0.14% of the portfolio and ranks #73 among its holdings.

440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

Vontobel Swiss Wealth Advisors held 27,895 shares of Teva Pharmaceuticals worth $276K as of Q2 2021.
Teva Pharmaceuticals was a new Vontobel Swiss Wealth Advisors position in Q2 2021.
Teva Pharmaceuticals made up 0.14% of Vontobel Swiss Wealth Advisors's portfolio in Q2 2021, its #73 holding.
440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.